Physician profile

James R Maxwell

Nephrology (Internal Medicine) · Jonesboro, AR

NPI 1689714024

$4,744.03

in general payments reported to CMS, 2019-2025

35 companies · $630 in 2025

The $630 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,842.72
Education$147.38

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $697.35 2019-2024 Farxiga, Lokelma
Vifor Pharma, INC. $424.57 2019-2025 Veltassa
Otsuka America Pharmaceutical, INC. $392.02 2019-2025 Jynarque
Amgen INC. $305.91 2019-2024 Aranesp, Tavneos, Parsabiv
Bayer Healthcare Pharmaceuticals INC. $262.10 2021-2025
Mallinckrodt Hospital Products INC. $215.01 2021-2025 Acthar
Boehringer Ingelheim Pharmaceuticals, INC. $213.55 2019-2025 Jardiance
Fresenius USA Marketing, INC. $211.44 2019-2024 Velphoro
Travere Therapeutics, INC. $202.53 2023-2025 Filspari
Mallinckrodt Enterprises LLC $182.14 2019
Glaxosmithkline, LLC. $177.25 2021-2025 Benlysta
Daiichi Sankyo INC. $171.17 2019-2024 Injectafer
Baxter Healthcare $162.63 2022-2024 Renal - Acute
Opko Pharmaceuticals, LLC $148.50 2019-2024 Rayaldee
Novartis Pharmaceuticals Corporation $113.62 2023-2025
Show all 35 companies
CompanyGeneral paymentsYearsTop products
Calliditas Therapeutics US INC. $98.98 2022-2025 Tarpeyo
Ardelyx, INC. $82.73 2024-2025 Ibsrela
Radius Health, INC. $73.42 2020-2022
Xeris Pharmaceuticals, INC. $72.78 2022
Akebia Therapeutics INC $63.69 2025 Vafseo
Sanofi-Aventis U.S. LLC $55.45 2020-2023
Nuwellis, INC. $55.06 2019-2020
Novo Nordisk INC $50.04 2019-2025 Rybelsus, Ozempic
Dexcom, INC. $49.52 2023-2024 Dexcom G6 Transmitter
Aurinia Pharma U.S., INC. $42.17 2023 Lupkynis
Lilly USA, LLC $37.95 2022
Abbvie INC. $29.95 2021
Scpharmaceuticals INC. $29.38 2025
Genzyme Corporation $21.67 2021
Tandem Diabetes Care, INC. $19.75 2022
Horizon Therapeutics Plc $18.93 2019
Ani Pharmaceuticals, INC. $17.47 2022
Abbott Laboratories $15.72 2019
Grifols USA, LLC $15.54 2019
Insulet Corporation $14.04 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

James R Maxwell

$4,744.03

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $630 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).

https://glasscript.com/doctor/212843/james-r-maxwell

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.